Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Disease-specific molecular events in cortical multiple sclerosis lesions.

Fischer MT, Wimmer I, Höftberger R, Gerlach S, Haider L, Zrzavy T, Hametner S, Mahad D, Binder CJ, Krumbholz M, Bauer J, Bradl M, Lassmann H.

Brain. 2013 Jun;136(Pt 6):1799-815. doi: 10.1093/brain/awt110. Epub 2013 May 17.

2.

NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.

Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, Lassmann H.

Brain. 2012 Mar;135(Pt 3):886-99. doi: 10.1093/brain/aws012.

3.

A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.

Merkler D, Ernsting T, Kerschensteiner M, Brück W, Stadelmann C.

Brain. 2006 Aug;129(Pt 8):1972-83. Epub 2006 May 19.

PMID:
16714315
4.

Oxidative damage in multiple sclerosis lesions.

Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H.

Brain. 2011 Jul;134(Pt 7):1914-24. doi: 10.1093/brain/awr128. Epub 2011 Jun 7.

5.

Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.

Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds R.

Brain. 2013 Dec;136(Pt 12):3596-608. doi: 10.1093/brain/awt279. Epub 2013 Oct 30.

PMID:
24176976
6.

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Peterson JW, Bö L, Mörk S, Chang A, Trapp BD.

Ann Neurol. 2001 Sep;50(3):389-400.

PMID:
11558796
7.

Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis.

Gray E, Thomas TL, Betmouni S, Scolding N, Love S.

Brain Pathol. 2008 Jan;18(1):86-95. Epub 2007 Nov 27.

PMID:
18042261
8.

Cortical remyelination: a new target for repair therapies in multiple sclerosis.

Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD.

Ann Neurol. 2012 Dec;72(6):918-26. doi: 10.1002/ana.23693. Epub 2012 Oct 17.

9.

Meningeal and cortical grey matter pathology in multiple sclerosis.

Popescu BF, Lucchinetti CF.

BMC Neurol. 2012 Mar 7;12:11. doi: 10.1186/1471-2377-12-11. Review.

10.

Inflammatory cortical demyelination in early multiple sclerosis.

Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM.

N Engl J Med. 2011 Dec 8;365(23):2188-97. doi: 10.1056/NEJMoa1100648.

11.

Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.

Kooi EJ, Geurts JJ, van Horssen J, Bø L, van der Valk P.

J Neuropathol Exp Neurol. 2009 Sep;68(9):1021-8. doi: 10.1097/NEN.0b013e3181b4bf8f.

PMID:
19680141
12.

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H.

Brain. 2005 Nov;128(Pt 11):2705-12. Epub 2005 Oct 17.

PMID:
16230320
13.

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.

Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W.

Brain. 2000 Jun;123 ( Pt 6):1174-83.

PMID:
10825356
14.

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R.

Ann Neurol. 2010 Oct;68(4):477-93. doi: 10.1002/ana.22230.

PMID:
20976767
15.

Neuronal injury in chronic CNS inflammation.

Zindler E, Zipp F.

Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Review.

PMID:
21619866
16.

Pathology of multiple sclerosis and related inflammatory demyelinating diseases.

Kutzelnigg A, Lassmann H.

Handb Clin Neurol. 2014;122:15-58. doi: 10.1016/B978-0-444-52001-2.00002-9. Review.

PMID:
24507512
17.

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F.

Brain. 2007 Apr;130(Pt 4):1089-104.

PMID:
17438020
18.

Cortical pathology in multiple sclerosis.

Stadelmann C, Albert M, Wegner C, Brück W.

Curr Opin Neurol. 2008 Jun;21(3):229-34. doi: 10.1097/01.wco.0000318863.65635.9a. Review.

PMID:
18451703
19.

Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.

Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.

J Neuropathol Exp Neurol. 2007 Aug;66(8):732-9.

PMID:
17882017
20.

Patterns of oligodendroglia pathology in multiple sclerosis.

Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassmann H.

Brain. 1994 Dec;117 ( Pt 6):1311-22.

PMID:
7820568

Supplemental Content

Support Center